Carson Wealth (CWM LLC)’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.6K Buy
9,234
+3,277
+55% +$12.9K ﹤0.01% 4042
2025
Q4
$23K Buy
5,957
+5
+0.1% +$22 ﹤0.01% 4103
2025
Q3
$28K Sell
5,952
-1,211
-17% -$4.38K ﹤0.01% 3934
2025
Q2
$22K Sell
7,163
-3,308
-32% -$10.7K ﹤0.01% 3860
2025
Q1
$35K Buy
10,471
+9,376
+856% +$43.8K ﹤0.01% 3271
2024
Q4
$6K Buy
1,095
+746
+214% +$4.81K ﹤0.01% 4158
2024
Q3
$2K Sell
349
-1,119
-76% -$8.14K ﹤0.01% 4476
2024
Q2
$12K Sell
1,468
-698
-32% -$5.85K ﹤0.01% 3459
2024
Q1
$20K Buy
2,166
+1,016
+88% +$8.58K ﹤0.01% 2923
2023
Q4
$10K Buy
+1,150
New +$8.34K ﹤0.01% 3209
2022
Q1
Sell
-45
Closed 3899
2021
Q4
$0 Buy
+45
New +$154 ﹤0.01% 3660

Other funds holding VYGR

Carson Wealth (CWM LLC)'s VYGR Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Voyager Therapeutics (VYGR) stake by 55% in Q1 2026, buying an estimated $12.9K and bringing the position to 9,234 shares worth $35.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4042.

Carson Wealth (CWM LLC) first reported a position in VYGR in Q4 2021 and has held it in 11 quarters since. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Carson Wealth (CWM LLC) held 9,234 shares of Voyager Therapeutics worth $35.6K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 3,277 Voyager Therapeutics shares in Q1 2026, an estimated $12.9K.
  • Voyager Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4042 holding.
  • Carson Wealth (CWM LLC) first reported a position in Voyager Therapeutics in Q4 2021 and has held it in 11 quarters since.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.